Incidence and Associated Factors of Anemia in Patients with Acute Moderate and Severe Traumatic Brain Injury.
Anemia
Critical care
Traumatic brain injury
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
07
02
2022
accepted:
17
06
2022
pubmed:
2
8
2022
medline:
22
11
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
Anemia might contribute to the development of secondary injury in patients with acute traumatic brain injury (TBI). Potential determinants of anemia are still poorly acknowledged, and reported incidence of declined hemoglobin concentration varies widely between different studies. The aim of this study was to investigate the incidence of severe anemia among patients with moderate to severe TBI and to evaluate patient- and trauma-related factors that might be associated with the development of anemia. This retrospective cohort study involved all adult patients admitted to Tampere University Hospital's emergency department for moderate to severe TBI (August 2010 to July 2012). Detailed information on patient demographics and trauma characteristics were obtained, including data on posttraumatic care, data on neurosurgical procedures, and all measured in-hospital hemoglobin values. Severe anemia was defined as a hemoglobin level less than 100 g/L. Both univariate and multivariable analyses were performed, and hemoglobin trajectories were created. The study included 145 patients with moderate to severe TBI (male 83.4%, mean age 55.0 years). Severe anemia, with a hemoglobin level less than 100 g/L, was detected in 66 patients (45.5%) and developed during the first 48 h after the trauma. In the univariate analysis, anemia was more common among women (odds ratio [OR] 2.84; 95% confidence interval [CI] 1.13-7.15), patients with antithrombotic medication prior to trauma (OR 3.33; 95% CI 1.34-8.27), patients with cardiovascular comorbidities (OR 3.12; 95% CI 1.56-6.25), patients with diabetes (OR 4.56; 95% CI 1.69-12.32), patients with extracranial injuries (OR 3.14; 95% CI 1.69-12.32), and patients with midline shift on primary head computed tomography (OR 2.03; 95% CI 1.03-4.01). In the multivariable analysis, midline shift and extracranial traumas were associated with the development of severe anemia (OR 2.26 [95% CI 1.05-4.48] and OR 4.71 [95% CI 1.74-12.73], respectively). Severe anemia is common after acute moderate to severe TBI, developing during the first 48 h after the trauma. Possible anemia-associated factors include extracranial traumas and midline shift on initial head computed tomography.
Sections du résumé
BACKGROUND
Anemia might contribute to the development of secondary injury in patients with acute traumatic brain injury (TBI). Potential determinants of anemia are still poorly acknowledged, and reported incidence of declined hemoglobin concentration varies widely between different studies. The aim of this study was to investigate the incidence of severe anemia among patients with moderate to severe TBI and to evaluate patient- and trauma-related factors that might be associated with the development of anemia.
METHODS
This retrospective cohort study involved all adult patients admitted to Tampere University Hospital's emergency department for moderate to severe TBI (August 2010 to July 2012). Detailed information on patient demographics and trauma characteristics were obtained, including data on posttraumatic care, data on neurosurgical procedures, and all measured in-hospital hemoglobin values. Severe anemia was defined as a hemoglobin level less than 100 g/L. Both univariate and multivariable analyses were performed, and hemoglobin trajectories were created.
RESULTS
The study included 145 patients with moderate to severe TBI (male 83.4%, mean age 55.0 years). Severe anemia, with a hemoglobin level less than 100 g/L, was detected in 66 patients (45.5%) and developed during the first 48 h after the trauma. In the univariate analysis, anemia was more common among women (odds ratio [OR] 2.84; 95% confidence interval [CI] 1.13-7.15), patients with antithrombotic medication prior to trauma (OR 3.33; 95% CI 1.34-8.27), patients with cardiovascular comorbidities (OR 3.12; 95% CI 1.56-6.25), patients with diabetes (OR 4.56; 95% CI 1.69-12.32), patients with extracranial injuries (OR 3.14; 95% CI 1.69-12.32), and patients with midline shift on primary head computed tomography (OR 2.03; 95% CI 1.03-4.01). In the multivariable analysis, midline shift and extracranial traumas were associated with the development of severe anemia (OR 2.26 [95% CI 1.05-4.48] and OR 4.71 [95% CI 1.74-12.73], respectively).
CONCLUSIONS
Severe anemia is common after acute moderate to severe TBI, developing during the first 48 h after the trauma. Possible anemia-associated factors include extracranial traumas and midline shift on initial head computed tomography.
Identifiants
pubmed: 35915348
doi: 10.1007/s12028-022-01561-9
pii: 10.1007/s12028-022-01561-9
pmc: PMC9671999
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
629-637Informations de copyright
© 2022. The Author(s).
Références
Neurocrit Care. 2008;8(3):337-43
pubmed: 18273711
Curr Opin Anaesthesiol. 2018 Apr;31(2):219-226
pubmed: 29369066
J Neurotrauma. 2007 Feb;24(2):315-28
pubmed: 17375996
Anesth Analg. 1995 Mar;80(3):492-8
pubmed: 7864413
Crit Care. 2009;13(3):R89
pubmed: 19519893
Am J Physiol. 1992 Jul;263(1 Pt 2):H75-82
pubmed: 1379006
Crit Care Med. 2004 Jan;32(1):39-52
pubmed: 14707558
Transfus Med Rev. 2016 Jan;30(1):15-24
pubmed: 26409622
Arch Phys Med Rehabil. 2010 Nov;91(11):1661-6
pubmed: 21044709
J Appl Physiol (1985). 1999 Aug;87(2):505-9
pubmed: 10444605
Crit Care. 2010;14(3):R92
pubmed: 20497535
World Neurosurg. 2016 Jun;90:82-90
pubmed: 26921698
Br J Anaesth. 1997 Sep;79(3):346-51
pubmed: 9389854
Crit Care. 2012 Jul 20;16(4):R128
pubmed: 22817913
J Trauma. 2009 Mar;66(3):720-6
pubmed: 19276744
Anesthesiology. 2000 Jun;92(6):1646-52
pubmed: 10839915
J Rehabil Med. 2005 May;37(3):137-41
pubmed: 16040469
Intensive Care Med. 2012 Sep;38(9):1497-504
pubmed: 22584800
J Trauma. 2006 Sep;61(3):567-71
pubmed: 16966988
Pharmacol Res. 2017 Apr;118:19-32
pubmed: 27521835
JAMA. 2002 Sep 25;288(12):1499-507
pubmed: 12243637
J Neurotrauma. 1994 Apr;11(2):149-60
pubmed: 7932795
BMJ Open. 2017 Mar 29;7(3):e014472
pubmed: 28360248
Crit Care Med. 2003 Feb;31(2):406-10
pubmed: 12576944
Crit Care Clin. 2017 Apr;33(2):345-364
pubmed: 28284299
J Appl Physiol (1985). 2007 Sep;103(3):1021-9
pubmed: 17556499
Intensive Care Med. 1996 Jan;22(1):47-51
pubmed: 8857437
Curr Treat Options Neurol. 2012 Feb 8;14(2):150-163
pubmed: 22314930
J Am Coll Surg. 2008 Sep;207(3):398-406
pubmed: 18722946
Crit Care. 2016 Jun 17;20(1):152
pubmed: 27311626